Lawsuit Alleges Big Pharma Cashing In On Ozempic Despite Side Effects | Cameron Stephenson | TMR
October 12, 2024
14,969
648
95
4.96%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Sam Seder Episodes Around October 12, 2024
See what was published immediately before and after this episode.
21:23Massive Online Company Held Accountable For CP | Attorney Kim Adams | TMR
21:26Now PlayingLawsuit Alleges Big Pharma Cashing In On Ozempic Despite Side Effects | Cameron Stephenson | TMR
YouTube Description
as posted by the channelLive-streamed on October 10, 2024
Cameron Stephenson dives into the recent proliferation of GLP-1RA drugs, from the FDA’s approval of Ozempic as a diabetes medication in 2017, through the now sixth variation between Novo Nordisk and Eli Lilly that focuses more on medical (or even cosmetic) weight loss, and the pharmaceutical industry’s complete failure to properly warn some millions and millions of patients about serious risks and side effects associated with the drug class – namely gastroparesis. After expanding on the particular role off-label marketing of cosmetic uses played in contributing to the pervasion of GLP-1RAs – despite the relatively minor financial penalties associated with it – Stephenson wraps up the interview by unpacking the impact of this pharmaceutical malpractice, and the importance of civil law in pushing for genuine change.
Watch the Majority Report live MondayFriday at 12 p.m. EST on YouTube OR listen via daily podcast at
#SamSeder #EmmaVigeland #MajorityReport #politics #news
Support the show by becoming a member
Get all your MR merch at our store
Gift a Majority Report subscription here
Subscribe to the AMQuickie newsletter here
Join the Majority Report Discord!
Get the free Majority Report App!
CHECK OUT MORE from the MR crew:
Matt Binder DOOMED
Brandon Sutton DISCOURSE
Emma Vigeland ESVN
Matt Lech LEFT RECKONING
OTHER LINKS:
Image Credit, Chemist4U
Image has been cropped and color has been altered.
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.